Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997

Journal of Infectious Diseases

Volumn 181, Issue 4, 2000, Pages 1435-1440

  Leake, John A D ^a,b   Mosley, David G ^c   England, Bob ^c   Graham, Justin V ^b   Plikaytis, Brian D ^b   Ampel, Neil M ^d   Perkins, Bradley A ^b   Hajjeh, Rana A ^b  

^a Epidemiology and Analysis Program Office   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c ARIZONA DEPARTMENT OF HEALTH SERVICES   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COCCIDIOIDOMYCOSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; VACCINATION;

EID: 0034121337     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315400     Document Type: Article

References (20)

1. 1. Galgiani J. Coccidioidomycosis. West J Med 1993; 159:153-71.
2. 2. Centers for Disease Control and Prevention. Coccidioidomycosis - Arizona, 1990 1995. MMWR Morb Mortal Wkly Rep 1996; 45:1069-73.
3. 3. Ampel NM, Mosely DM, England R, Komatsu K, Hejjeh R. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin Infect Dis 1998; 27:1528-30.
4. 4. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997; 46:1-55.
5. 5. Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984; 120:825-33.
6. 6. Bruzzi P, Green SB, Byar DP, Brinton LP, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985; 122:904-14.
7. 7. Kirkland T, Fierer J. Coccidioidomycosis, a reemerging infectious disease. Emerg Infect Dis 1996; 2:192-9.
8. 8. Kerrick SS, Lundergan LL, Gulgiani JN. Coccidioidomycosis at a university health service. Am Rev Respir Dis 1985; 131:100-2.
9. 9. Levitz SM. Overview of host defenses in fungal infections. Clin Infect Dis 1992; 14(Suppl 1):S37-42.
10. 10. Rosenstein N. Coccidioidomycosis: risk factors for severe pulmonary and disseminated disease, Kern County, California [abstract 637]. In: Proceedings of the 35th annual meeting of the Infectious Diseases Society of America (San Francisco). Washington, DC: Infectious Diseases Society of America, 1997.
11. 11. Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J 1997; 16:979-83.
12. 12. Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis 1999; 179:449-54.
13. 13. Salazar ME, Restrepo A, Stevens DA. Inhibition by estrogens of conidium-to-yeast conversion in the fungus Paracoccidioides brasiliensis. Infect Immun 1988; 56:711-3.
14. 14. Centers for Disease Control and Prevention. Blastomycosis - Wisconsin, 1986-1995. MMWR Morb Mortal Wkly Rep 1996; 45:601-3.
15. 15. US Census Bureau. http://www.census.gov. Accessed July and August, 1997.
16. 16. Wacholder S, Silverman DT. McLaughlin JK, Mandel JS. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992; 135:1029-41.
17. 17. Hennekens CH, Buring JE. Case-control studies. In: Mayrent SL, ed. Epidemiology in Medicine. 1st ed. Boston: Little, Brown, 1987:132-52.
18. 18. Pappagianis D, Zimmer B. Serology of coccidioidomycosis. Clin Microbiol Rev 1990; 3:247-68.
19. 19. Deepe GS Jr. Prospects for the development of fungal vaccines. Clin Microbiol Rev 1997; 10:585-96.
20. The Journal of Infectious Diseases 2000; 181:1441-6